Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan Timothy Eugene
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dunlop A. Sinclair
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Deschatelets Pascal
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan Timothy Eugene
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Dunlop A. Sinclair
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer DeLong Mark Jeffrey
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Chopas James George
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Nicholson Nur
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Deschatelets Pascal
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Watson David O.
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Francois Cedric
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan Timothy Eugene
Apellis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(9.4%),Oleg Nodelman(9.4%), etc.
Apellis Pharmaceuticals | SC 13G: Statement of acquisition of beneficial ownership by individuals-T. Rowe Price Investment Management, Inc.(5.3%)
Apellis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Avoro Capital Advisors LLC(9.9%),Behzad Aghazadeh(9.9%)
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Townsend Adam J.
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Watson David O.
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan Timothy Eugene
Apellis Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(8.06%)
Apellis Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Francois Cedric
No Data